
NEE · NYSE
The supplied consensus is Hold from 17 analysts. Reported targets run from $114 to $114, implying no dispersion in the stated low-to-high range, while the reported mean is $100.5; the figures are internally inconsistent because the mean is below the stated range. The evidence does not identify which analyst or firm is most bullish or least bullish. It also provides no attributable rating revisions during the week. The only specifically named recent action is Morgan Stanley lowering its target to $114 from $116 on August 21, before the period under review. The substantive debate is valuation versus growth: investors must weigh NEE’s premium positioning, merger-related prospects, and the DOE-supported nuclear restart against weaker fiscal-year net-income growth and execution risk.
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| Morgan Stanley | — | $114 | +39.7% | Aug 21, 2026 | Open the report this row came from | |
| Morgan Stanley | — | $114 | +39.7% | Aug 19, 2026 |
| Morgan Stanley | — | $116 | +42.1% | Jul 22, 2026 | Open the report this row came from |